AIM
ARK Investment Management’s Editas Medicine EDIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-17
| Closed | -$151 | – | 224 |
|
|
2022
Q4 | $151 | Sell |
17
-145,275
| -100% | -$1.29M | ﹤0.01% | 231 |
|
|
2022
Q3 | $1.78M | Sell |
145,292
-108,034
| -43% | -$1.32M | 0.01% | 201 |
|
|
2022
Q2 | $2.89M | Sell |
253,326
-543,915
| -68% | -$6.19M | 0.02% | 166 |
|
|
2022
Q1 | $15.2M | Sell |
797,241
-3,421,061
| -81% | -$65.1M | 0.06% | 118 |
|
|
2021
Q4 | $112M | Sell |
4,218,302
-2,079,057
| -33% | -$55.2M | 0.34% | 52 |
|
|
2021
Q3 | $259M | Sell |
6,297,359
-882,696
| -12% | -$36.3M | 0.62% | 41 |
|
|
2021
Q2 | $407M | Sell |
7,180,055
-1,571,868
| -18% | -$89M | 0.76% | 35 |
|
|
2021
Q1 | $368M | Sell |
8,751,923
-1,373,641
| -14% | -$57.7M | 0.73% | 43 |
|
|
2020
Q4 | $710M | Sell |
10,125,564
-544,860
| -5% | -$38.2M | 1.89% | 12 |
|
|
2020
Q3 | $299M | Buy |
10,670,424
+3,124,278
| +41% | +$87.7M | 1.78% | 15 |
|
|
2020
Q2 | $223M | Buy |
7,546,146
+2,210,205
| +41% | +$65.4M | 2.4% | 12 |
|
|
2020
Q1 | $106M | Buy |
5,335,941
+888,664
| +20% | +$17.6M | 2.64% | 13 |
|
|
2019
Q4 | $132M | Sell |
4,447,277
-485,121
| -10% | -$14.4M | 3.32% | 7 |
|
|
2019
Q3 | $112M | Buy |
4,932,398
+84,250
| +2% | +$1.92M | 2.45% | 15 |
|
|
2019
Q2 | $120M | Buy |
4,848,148
+288,714
| +6% | +$7.14M | 3.02% | 10 |
|
|
2019
Q1 | $111M | Buy |
4,559,434
+1,534,945
| +51% | +$37.5M | 3.19% | 10 |
|
|
2018
Q4 | $68.8M | Buy |
3,024,489
+230,635
| +8% | +$5.25M | 2.79% | 13 |
|
|
2018
Q3 | $88.9M | Buy |
2,793,854
+612,282
| +28% | +$19.5M | 2.69% | 11 |
|
|
2018
Q2 | $78.2M | Buy |
2,181,572
+561,364
| +35% | +$20.1M | 2.86% | 11 |
|
|
2018
Q1 | $53.7M | Buy |
1,620,208
+507,363
| +46% | +$16.8M | 2.67% | 11 |
|
|
2017
Q4 | $34.2M | Buy |
1,112,845
+424,975
| +62% | +$13.1M | 2.72% | 8 |
|
|
2017
Q3 | $16.5M | Buy |
687,870
+177,683
| +35% | +$4.27M | 2.02% | 15 |
|
|
2017
Q2 | $8.56M | Buy |
510,187
+280,265
| +122% | +$4.7M | 1.67% | 25 |
|
|
2017
Q1 | $5.13M | Buy |
+229,922
| New | +$5.13M | 1.48% | 27 |
|